[P-selectin as endothelial reactivity marker in patients with pre-eclampsia]
Related Experiment Video
Updated: Aug 11, 2026
Analysis of Physiologic E-Selectin-Mediated Leukocyte Rolling on Microvascular Endothelium
Published on: February 10, 2009
José Daniel Salazar-Exaire1, Ruth Iliana Reyes-Martínez, Raúl González-Alvarez
1Unidad de Investigación Hospital de Especialidades, México.
Insights
P-selectin, a platelet marker, is significantly elevated in pre-eclampsia, indicating endothelial activation. This finding highlights P-selectin
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Vascular Biology
Context:
- Pre-eclampsia is a pregnancy complication affecting 5% of pregnancies.
- It is characterized by endothelial dysfunction and platelet activation.
- P-selectin is a molecule expressed on platelet membranes, involved in endothelial regulation.
Purpose:
- To investigate the role of P-selectin in endothelial reactivity in pre-eclampsia.
- To compare P-selectin levels in patients with severe pre-eclampsia versus normal pregnancies.
Summary:
- Blood samples from 30 severe pre-eclampsia patients and 30 normal pregnancy controls were analyzed for P-selectin expression using ELISA.
- A significant difference in P-selectin expression was observed between the two groups.
- Elevated P-selectin levels were identified in patients with severe pre-eclampsia.
Impact:
- P-selectin serves as a valuable marker for endothelial activation in pre-eclampsia.
- This research contributes to understanding the pathophysiology of pre-eclampsia.
- Findings may inform diagnostic or therapeutic strategies for pre-eclampsia.
Introduction:
Pre-eclampsia affects 5% of all pregnancies. The physiopathologic hallmark is altered endothelium function and platelet activation. Selectins are molecules involved with the regulation between these systems, P-selectin is a molecule expressed in platelet membrane. Our objective was to describe the role of P-selectin on endothelial reactivity in patients with pre-eclampsia compared with normal pregnancies.
Material And Methods:
Blood samples from 30 patients with severe pre-eclampsia (cases) were compared with patients with 30 normal pregnancies during labor (controls). Samples from both groups were analyzed using ELISA (Bender Med kit, Vienna, Austria) for determination of P-selectin.
Results:
We compared main clinical, biochemical, and hematologic variables in both groups, identifying an outstanding difference in expression of P-selectin between them.
Conclusions:
P-selectin is a marker of endothelium activation in patients with severe pre-eclampsia.
